US 8685936
Sphingosine kinase inhibitor prodrugs
granted A61KA61K31/165A61P
Quick answer
US patent 8685936 (Sphingosine kinase inhibitor prodrugs) held by Apogee Biotechnology Corporation expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apogee Biotechnology Corporation
- Grant date
- Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/165, A61P, A61P1/00, A61P1/02